HIV-HCV coinfected patients, followed prospectively for a mean of 4.2 years, have similar rates of death or cirrhosis compared to HCV monoinfected patients.

被引：0
|
作者：
Monto, A
Dove, LM
Seal, KH
Miller, E
Lebel, A
Shen, H
Tracy, D
Wright, TL
机构：
[1] Columbia Univ, New York, NY USA
[2] UCSF, VAMC, San Francisco, CA USA
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：692A / 693A
页数：2
相关论文
共 40 条
  • [31] Lymphomas incidence in HIV/HCV coinfected versus HIV monoinfected patients over twenty-one years of follow up (1993-2014)
    de Cea, A. M.
    Rodriguez-Osorio, I.
    Meijide, H.
    Balinas, J.
    Pedreira, J. D.
    Castro Iglesias, M. de los Angeles
    JOURNAL OF HEPATOLOGY, 2018, 68 : S318 - S318
  • [32] EARLY VIROLOGICAL RESPONSE RATES IN MONOINFECTED PATIENTS WITH HCV AND COINFECTED WITH HCV/HIV, GENOTYPES 1&4 TREATED WITH PEGINTERFERON alpha 2a AND RIBAVIRIN. OPTIM STUDY
    Romero-Gomez, M.
    de Cuenca, B.
    Baeyens, E.
    Garcia-Samaniego, J.
    Salmeron, J.
    Alonso, M. D. M.
    Buenestado, J.
    Munoz, R.
    Diago, M.
    Garcia, A.
    Minguez, C.
    Morano, L.
    Giron, J. A.
    Sanchez, J. J.
    Gonzalez-Garcia, J. J.
    Sola, R.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S367 - S368
  • [33] Direct oral anticoagulants have similar rates of bleeding compared to traditional anticoagulants in compensated cirrhosis patients.
    Intagliata, Nicolas
    Henry, Zachary
    Maitland, Hillary
    Shah, Neeral L.
    Argo, Curtis K.
    Northup, Patrick
    Caldwell, Stephen H.
    HEPATOLOGY, 2015, 62 : 588A - 589A
  • [34] Patients coinfected with HCV and HIV who achieve an RVR (HCV RNA <50 IU/mL at week 4) or cevr (HCV RNA <50 IU/mL at week 12) have similar rates of SVR to monoinfected patients treated with peginterferon alfa-2a (40kd) (pegasys®) and ribavirin (copegus®)
    Rodriguez-Torres, Maribel
    Torriani, Francesca
    Rockstroh, Juergen
    Depamphilis, Jean
    Carosi, Giampiero
    Dieterich, Douglas T.
    HEPATOLOGY, 2007, 46 (04) : 814A - 814A
  • [35] PERFORMANCE OF LIVER STIFFNESS COMPARED WITH LIVER BIOPSY TO PREDICT SURVIVAL AND DECOMPENSATIONS OF CIRRHOSIS AMONG HIV/HCV-COINFECTED PATIENTS
    Macias, J.
    Camacho, A.
    von Wichmann, M. A.
    Lopez-Cortes, L. F.
    Ortega, E.
    Tural, C.
    Rios, M. J.
    Merino, D.
    Tellez, F.
    Marquez, M.
    Pineda, J. A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S9 - S9
  • [36] Hepatic toxicity of etravirine (ETV) in HIV-monoinfected and HIV-HCV coinfected patients enrolled in the expanded access program (EAP) in the outpatient HIV-clinic of the Institute of Infectious and Tropical Dieseases of Brescia (Italy)
    Gatti, F.
    Nasta, P.
    Izzo, I.
    Paraninfo, G.
    Borghi, F.
    Carosi, G.
    INFECTION, 2010, 38 : 59 - 59
  • [37] HIV/HCV-coinfected cirrhotic patients are no longer at higher risk of hepatocellular carcinoma or end-stage liver disease as compared to HCV-monoinfected patients (ANRS CO12 CirVir and ANRS CO13 HEPAVIH cohorts)
    Salmon, D.
    Nahon, P.
    Layese, R.
    Bourcier, V.
    Audureau, E.
    Gilbert, C.
    Esterle, L.
    Dabis, F.
    Wittkop, L.
    Roudot-Thoraval, F.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S72 - S73
  • [38] The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis
    Down, Carrie
    Mehta, Natasha
    Marks, Kristen
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (09) : 868 - 871
  • [39] Hepatitis C viral load is increased and related to genotype 1 in HVC+/HIV+ co-infection compared with HCV plus non-coinfected patients.
    Bessone, F
    Daruich, J
    Lupo, S
    Agostini, M
    Manero, E
    Sordá, J
    Palazzi, J
    Nakatsuno, M
    Reboredo, G
    Reggiardo, MV
    Godoy, A
    Passamonti, ME
    Vorobioff, J
    Findor, J
    Tanno, H
    HEPATOLOGY, 2003, 38 (04) : 449A - 449A
  • [40] High SVR 12 rates following treatment with direct acting antiviral agents (DAA) in a German multicentre cohort of HCV/HIV-1 coinfected patients on the transplant waiting list with advanced liver cirrhosis
    Schwarz, J.
    Werner, C.
    Steurer, M.
    Spengler, U.
    Wedemeyer, H.
    von Hahn, T.
    Stremmel, W.
    Pathil-Warth, A.
    Berg, T.
    Engelmann, C.
    Seybold, U.
    Schott, E.
    Blessin, U.
    Malek, N.
    Lauer, U.
    Berg, C.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S526 - S526
1234